Community-based program to improve postpartum health for Black women

Dissemination and Implementation of a Community-driven Approach to Improve the Health of Women, Infants, and Families: Pre-implementation Phase to Adapt Staying Healthy After Childbirth (STAC)

Not applicable Interventional University of Wisconsin, Madison · NCT06689930

This study is testing a new program to help Black women stay healthy after childbirth by providing them with tools and support to manage high blood pressure.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment46 (estimated)
Ages18 Years and up
SexAll
SponsorUniversity of Wisconsin, Madison Academic / other
Locations1 site (Madison, Wisconsin)
Trial IDNCT06689930 on ClinicalTrials.gov

What this trial studies

This project adapts the Staying Healthy After Childbirth (STAC) intervention to better serve Black women and birthing persons by addressing hypertensive disorders of pregnancy. It focuses on the critical postpartum period, where the risk of serious health outcomes is highest. The intervention includes providing home blood pressure monitors and access to a healthcare team for remote monitoring and medication management. Community engagement is emphasized to ensure the intervention meets the needs of the target population through qualitative feedback from community advisory board members and lived experience groups.

Who should consider this trial

Good fit: Ideal candidates include pregnant individuals who are at least 24 weeks gestation or postpartum, self-identify as African American or Black, and are 18 years or older.

Not a fit: Patients with certain medical conditions such as chronic kidney disease requiring dialysis or known unrepaired congenital heart disease may not benefit from this intervention.

Why it matters

Potential benefit: If successful, this program could significantly reduce health disparities and improve postpartum health outcomes for Black women.

How similar studies have performed: Other studies have shown success with community-based interventions aimed at reducing health disparities, making this approach promising yet tailored for a specific population.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria (Interviews and Focus Groups):

* Belong to the STAC-CAB or Lived Experience Group
* Aged 18 or older

Inclusion Criteria (CBO Staff):

* Staff of CBO participating in PDSA cycle
* Aged 18 years or older

Inclusion Criteria (PDSA-Cycles):

* Pregnant persons greater than or equal to 24 weeks gestation and prior to delivery or postpartum
* Self-Identify as African American or Black
* Aged 18 years or older
* Capable of providing informed consent in English
* Can follow M•care System use instructions in English
* Have ownership of a functioning and reliable smartphone to upload and use the M•other App
* Interested in preventing or managing blood pressure during pregnancy

Exclusion Criteria (PDSA-Cycles):

* Persistent second or third trimester bleeding at time of enrollment
* Premature rupture of membranes in the current pregnancy at time of enrollment
* Known unrepaired maternal congenital heart disease requiring surgical correction
* Maternal heart failure
* Chronic kidney disease specifically requiring dialysis
* On greater than two antihypertensive medications at time of enrollment

Where this trial is running

Madison, Wisconsin

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Blood PressureHypertensionPregnancy RelatedHealth EquityPrenatalPost PartumHypertensive Disorders of PregnancyRemote Patient Monitoring
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.